1887

Abstract

Hepatitis C virus (HCV) replicon-harbouring cell lines possessing interferon (IFN)-resistant phenotypes have recently been established. These were divided into two classes: partially IFN resistant and highly IFN resistant. Here, the viral and cellular factors contributing to the IFN resistance of HCV replicon-harbouring cells were evaluated. The results revealed that cellular factors rather than viral factors contributed to a highly IFN-resistant phenotype. The possibility of genetic abnormality of the factors involved in IFN signalling was investigated. As a result, nonsense mutations and deletions in type I IFN receptor genes (IFNAR1 and IFNAR2c) were found in replicon-harbouring cells showing a highly IFN-resistant phenotype, but rarely appeared in cells showing a partially IFN-resistant phenotype. Furthermore, similar genetic alterations were also found in IFN-resistant phenotype, replicon-harbouring cell lines obtained additionally by IFN- treatment. Moreover, it was shown that ectopic expression of wild-type IFNAR1 in IFN-resistant phenotype, replicon-harbouring cells possessing the IFNAR1 mutant restored type I IFN signalling.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81124-0
2005-10-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/10/2787.html?itemId=/content/journal/jgv/10.1099/vir.0.81124-0&mimeType=html&fmt=ahah

References

  1. Akagi, T., Shishido, T., Murata, K. & Hanafusa, H. ( 2000; ). v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A 97, 7290–7295.[CrossRef]
    [Google Scholar]
  2. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. ( 1989; ). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.[CrossRef]
    [Google Scholar]
  3. Dansako, H., Naganuma, A., Nakamura, T., Ikeda, F., Nozaki, A. & Kato, N. ( 2003; ). Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res 97, 17–30.[CrossRef]
    [Google Scholar]
  4. Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. ( 2001; ). Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82, 723–733.
    [Google Scholar]
  5. Frese, M., Schwarzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O. & Bartenschlager, R. ( 2002; ). Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694–703.[CrossRef]
    [Google Scholar]
  6. Hadziyannis, S. J., Sette, H., Jr, Morgan, T. R. & 11 other authors ( 2004; ). Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140, 346–355.[CrossRef]
    [Google Scholar]
  7. Hijikata, M., Mizushima, H., Tanji, Y., Komoda, Y., Hirowatari, Y., Akagi, T., Kato, N., Kimura, K. & Shimotohno, K. ( 1993; ). Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90, 10773–10777.[CrossRef]
    [Google Scholar]
  8. Ikeda, M., Yi, M., Li, K. & Lemon, S. M. ( 2002; ). Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76, 2997–3006.[CrossRef]
    [Google Scholar]
  9. Ikeda, M., Abe, K., Dansako, H., Nakamura, T., Naka, K. & Kato, N. ( 2005; ). Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329, 1350–1359.[CrossRef]
    [Google Scholar]
  10. Kato, N. ( 2001; ). Molecular virology of hepatitis C virus. Acta Med Okayama 55, 133–159.
    [Google Scholar]
  11. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. & Shimotohno, K. ( 1990; ). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87, 9524–9528.[CrossRef]
    [Google Scholar]
  12. Kato, N., Sugiyama, K., Namba, K., Dansako, H., Nakamura, T., Takami, M., Naka, K., Nozaki, A. & Shimotohno, K. ( 2003; ). Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306, 756–766.[CrossRef]
    [Google Scholar]
  13. Kato, N., Nakamura, T., Dansako, H., Namba, K., Abe, K., Nozaki, A., Naka, K., Ikeda, M. & Shimotohno, K. ( 2005; ). Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J Gen Virol 86, 645–656.[CrossRef]
    [Google Scholar]
  14. Kishine, H., Sugiyama, K., Hijikata, M. & 7 other authors ( 2002; ). Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem Biophys Res Commun 293, 993–999.[CrossRef]
    [Google Scholar]
  15. Kuo, G., Choo, Q. L., Alter, H. J. & 17 other authors ( 1989; ). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362–364.[CrossRef]
    [Google Scholar]
  16. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. & Bartenschlager, R. ( 1999; ). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113.[CrossRef]
    [Google Scholar]
  17. Machida, K., Cheng, K. T.-N., Sung, V. M.-H., Lee, K. J., Levine, A. M. & Lai, M. M. ( 2004a; ). Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78, 8835–8843.[CrossRef]
    [Google Scholar]
  18. Machida, K., Cheng, K. T.-N., Sung, V. M.-H., Shimodaira, S., Lindsay, K. L., Levine, A. M., Lai, M.-Y. & Lai, M. M. ( 2004b; ). Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101, 4262–4267.[CrossRef]
    [Google Scholar]
  19. Naganuma, A., Nozaki, A., Tanaka, T., Sugiyama, K., Takagi, H., Mori, M., Shimotohno, K. & Kato, N. ( 2000; ). Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol 74, 8744–8750.[CrossRef]
    [Google Scholar]
  20. Naganuma, A., Dansako, H., Nakamura, T., Nozaki, A. & Kato, N. ( 2004; ). Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells. Cancer Res 64, 1307–1314.[CrossRef]
    [Google Scholar]
  21. Naka, K., Ikeda, M., Abe, K., Dansako, H. & Kato, N. ( 2005; ). Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-α. Biochem Biophys Res Commun 330, 871–879.[CrossRef]
    [Google Scholar]
  22. Namba, K., Naka, K., Dansako, H., Nozaki, A., Ikeda, M., Shiratori, Y., Shimotohno, K. & Kato, N. ( 2004; ). Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. Biochem Biophys Res Commun 323, 299–309.[CrossRef]
    [Google Scholar]
  23. Nozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K. & Kato, N. ( 2003; ). Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J Biol Chem 278, 10162–10173.[CrossRef]
    [Google Scholar]
  24. Pawlotsky, J. M. ( 2000; ). Hepatitis C virus resistance to antiviral therapy. Hepatology 32, 889–896.[CrossRef]
    [Google Scholar]
  25. Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W. & Yang, C. H. ( 1997; ). STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276, 1418–1420.[CrossRef]
    [Google Scholar]
  26. Saito, I., Miyamura, T., Ohbayashi, A. & 10 other authors ( 1990; ). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87, 6547–6549.[CrossRef]
    [Google Scholar]
  27. Thomas, D. L. ( 2000; ). Hepatitis C epidemiology. Curr Top Microbiol Immunol 242, 25–41.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81124-0
Loading
/content/journal/jgv/10.1099/vir.0.81124-0
Loading

Data & Media loading...

Supplements

vol. , part 10, pp. 2787 - 2792

Genetic mutations found in type I IFN receptors Outline of the isolation of HCV replicon cells possessing IFN-resistant phenotypes Ectopic expression of wild-type IFNAR1 Molecular mechanisms of IFN resistance Genetic alterations of IFN receptors in the newly isolated HCV replicon cell lines possessing IFN-resistant phenotypes [Single PDF file](224 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error